nach oben

Erschienen in:

14.11.2018 | Case Report

Vaccine strain Listeria monocytogenes bacteremia occurring 31 months after immunization

verfasst von: Elias Fares, Cindy B. McCloskey, Andres Gutierrez, Michael Princiotta, Linda J. Salinas, Douglas A. Drevets

Erschienen in: Infection | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Listeria monocytogenes is a food-borne, facultative intracellular bacterium that causes severe diseases such as sepsis and meningoencephalitis in immunocompromised hosts. Because it stimulates robust T-lymphocyte-mediated responses, attenuated L. monocytogenes are candidate vaccine vectors for tumor immunotherapy.

Case

We report a case of bacteremia caused by vaccine strain L. monocytogenes (Axalimogene filolisbac) occurring 31 months after immunization against human papilloma virus (HPV) associated cervical cancer.

Conclusion

Receipt of a L. monocytogenes-based vaccine is a novel risk factor for delayed L. monocytogenes bacteremia.

Lorber B. Listeria monocytogenes. In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Philadelphia: Elsevier Saunders; 2015. pp. 2383–90.

Silk BJ, Mahon BE, Griffin PM, Gould LH, Tauxe RV, Crim SM, et al. Listeria illness, deaths, and outbreaks—United States, 2009–2011. MMWR. 2013;62:228–452.

Charlier C, Perrodeau É, Leclercq A, Cazenave B, Pilmis B, Henry B, et al. Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study. Lancet Infect Dis. 2017;17:510–9. https://doi.org/10.1016/S1473-3099(16)30521-7.CrossRefPubMed

Wood LM, Paterson Y. Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy. Front Cell Infect Microbiol. 2014;4:1–22. https://doi.org/10.3389/fcimb.2014.00051.CrossRef

Maciag PC, Radulovic S, Rothman J. The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix. Vaccine. 2009;27:3975–83. https://doi.org/10.1016/j.vaccine.2009.04.041.CrossRefPubMed

Miles BA, Monk BJ, Safran HP. Mechanistic insights into ADXS11-001 Human papillomavirus-associated cancer immunotherapy. Gynecol Oncol Res Pract. 2017;4:9. https://doi.org/10.1186/s40661-017-0046-9.CrossRefPubMedPubMedCentral

McLauchlin J, Audurier A, Taylor AG. Treatment failure and recurrent human listeriosis. J Antimicrob Chemother. 1991;27:851–7.CrossRefPubMed

Levett PN, Bennett P, O’Donaghue K, Bowker K, Reeves D, MacGowan A. Relapsed infection due to Listeria monocytogenes confirmed by random amplified polymorphic DNA (RAPD) analysis. J Infect. 1993;27:205–7.CrossRefPubMed

Sauders BD, Wiedmann M, Desjardins M, Fenlon C, Davenport N, Hibbs JR, et al. Recurrent Listeria monocytogenes infection: relapse or reinfection with a unique strain confirmed by molecular subtyping. Clin Infect Dis. 2001;33:257–9. https://doi.org/10.1086/321821.CrossRefPubMed

10.

Ciceri G, Gori M, Bianchi S, Corrado G, Panisi P, Papa A, et al. Molecular evidence of Listeria monocytogenes infection relapse in a severe case of endocarditis. JMM Case Rep. 2017;4:e005115. https://doi.org/10.1099/jmmcr.0.005115.CrossRefPubMedPubMedCentral

11.

Radoshevich L, Cossart P. Listeria monocytogenes: towards a complete picture of its physiology and pathogenesis. Nat Rev Microbiol. 2017;16:32. https://doi.org/10.1038/nrmicro.2017.126.CrossRefPubMed

12.

Advaxis. ADXS11-001 Investigator Brochure V.15. Lm-LLO Immunotherapy for the treatment of HPV-associated cancers. 2018.

13.

Denham JD, Lee DH, Castro M, Pandya S, Aslam S, Nanjappa S, et al. Two cases of disseminated infection following live organism anti-cancer vaccine administration in cancer patients. Int J Infect Dis. 2018;72:1–2. https://doi.org/10.1016/j.ijid.2018.04.004.CrossRefPubMed

14.

Drevets DA. Listeria monocytogenes virulence factors that stimulate endothelial cells. Infect Immun. 1998;66:232–8.PubMedPubMedCentral

15.

Charlier C, Leclercq A, Cazenave B, Desplaces N, Travier L, Cantinelli T, et al. Listeria monocytogenes–associated joint and bone infections: a study of 43 consecutive cases. Clin Infect Dis. 2012;54:240–8. https://doi.org/10.1093/cid/cir803.CrossRefPubMed

16.

Lemon KP, Freitag NE, Kolter R. The virulence regulator PrfA promotes biofilm formation by Listeria monocytogenes. J Bacteriol. 2010;192:3969–76. https://doi.org/10.1128/jb.00179-10.CrossRefPubMedPubMedCentral

17.

Einhorn TA, Gerstenfeld LC. Fracture healing: mechanisms and interventions. Nat Rev Rheumatol. 2015;11:45–54. https://doi.org/10.1038/nrrheum.2014.164.CrossRefPubMed

18.

Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12:252–64.CrossRefPubMedPubMedCentral

19.

Stein MN, Fong L, Tutrone RF, Mega AE, Lobo M, Hong Q, et al. KEYNOTE-046: ADXS-PSA plus pembrolizumab (pembro) in metastatic castration-resistant prostate cancer (mCRPC). J Clin Oncol. 2018;36(suppl):abstr 5019.CrossRef

20.

Becattini S, Littmann ER, Carter RA, Kim SG, Morjaria SM, Ling L, et al. Commensal microbes provide first line defense against Listeria monocytogenes infection. J Exp Med. 2017. https://doi.org/10.1084/jem.20170495.CrossRefPubMedPubMedCentral

Titel: Vaccine strain Listeria monocytogenes bacteremia occurring 31 months after immunization
verfasst von: Elias Fares
Cindy B. McCloskey
Andres Gutierrez
Michael Princiotta
Linda J. Salinas
Douglas A. Drevets
Publikationsdatum: 14.11.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Infection / Ausgabe 3/2019
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI: https://doi.org/10.1007/s15010-018-1249-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Vaccine strain Listeria monocytogenes bacteremia occurring 31 months after immunization

Abstract

Background

Case

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin

Springer Medizin

Abstract

Background

Case

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Recurrent cholera epidemics in Africa: which way forward? A literature review

Urinary schistosomiasis in migrant population: a case series from a single centre in southern Italy

Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected patients

Treatment of a broncho-esophageal fistula complicated by severe ARDS

The diagnosis and treatment of urogenital schistosomiasis in Italy in a retrospective cohort of immigrants from Sub-Saharan Africa

Antagonistic effect between tigecycline and meropenem: successful management of KPC-producing Klebsiella pneumoniae infection

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin